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Origins of Peptide Selectivity and
Phosphoinositide Binding Revealed by Structures
of Disabled-1 PTB Domain Complexes
ataxic reeler mouse, which results from a naturally oc-
curring null mutation in the reelin gene [5]. The connec-
tion between Reelin, a secreted protein found in the
extracellular matrix, and Dab1, a cytosolic adaptor pro-
tein, was revealed when double-knockout mice lacking
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3 Department of Molecular Genetics terminus of Dab1 mediates binding to the cytoplasmic
tails of the lipoprotein receptors [9, 10]. This domain isUniversity of Texas Southwestern Medical Center
Dallas, Texas 75390 required for normal Dab1 function and is shared among
the three known isoforms of Dab1 [11]. All isoforms also
include a tyrosine-rich sequence immediately C-ter-
minal to the PTB domain, with variations resulting fromSummary
alternative splicing occurring downstream (Figure 1A).
Though PTB is an acronym for “phosphotyrosine bind-Formation of the mammalian six-layered neocortex
depends on a signaling pathway that involves Reelin, ing” [12–14], PTB domains exhibit remarkable plasticity
in their ability to recognize different peptide motifs. Inthe very low-density lipoprotein receptor, the apolipo-
protein E receptor-2 (ApoER2), and the adaptor protein Dab1, the PTB domain selectively recognizes peptides
with the consensus sequence φxNPxY (where φ repre-Disabled-1 (Dab1). The 1.5 A˚ crystal structure of a
complex between the Dab1 phosphotyrosine binding sents F or Y, x represents relaxed amino acid selectivity,
and Y is designated the “0” position on the basis of(PTB) domain and a 14-residue peptide from the
ApoER2 tail explains the unusual preference of Dab1 prior convention). In contrast to most other PTB domains
that bind tyrosine-based motifs either with preferencefor unphosphorylated tyrosine within the NPxY motif
of the peptide. Crystals of the complex soaked with for phosphotyrosine (at the 0 position) or indifference
to the phosphorylation state of the tyrosine, the PTBthe phosphoinositide PI-4,5P2 (PI) show that PI binds
to conserved basic residues on the PTB domain oppo- domain of Dab1 favors unphosphorylated tyrosine over
phosphotyrosine by almost two orders of magnitudesite the peptide binding groove. This finding explains
how the Dab1 PTB domain can simultaneously bind [15]. In accordance with this observed selectivity, the
tyrosine of the NPxY motif of each receptor is believedPI and the ApoER2 tail. Recruitment of the Dab1 PTB
domain to PI-rich regions of the plasma membrane to be unphosphorylated at rest, and whether receptor
activity is regulated by phosphorylation on the NPxYmay facilitate association with the Reelin receptor cy-
toplasmic tails to transduce a critical positional cue tyrosine is not yet known.
PTB domains structurally resemble pleckstrin homol-to migrating neurons.
ogy (PH) domains, which bind to a variety of different
phospholipids with varying specificity [16–18]. Indeed,Introduction
previous studies have shown that the Dab1 PTB domain
binds phosphoinositides (PIs) [15], with selectivity forThe mammalian Disabled-1 (Dab1) gene is one of two
known mammalian orthologs of Drosophila Disabled, a phosphatidylinositol-4,5-bisphosphate (PI-4,5P2), al-
though the significance of PI-4,5P2 binding by Dab1 hasgene required for proper development of the fly central
nervous system [1, 2]. Genetic and biochemical studies not yet been elucidated. Binding of PI-4,5P2 can occur
in the absence of peptide and does not prevent peptideof Dab1 in mice and in humans have shown that it is
required for the migration of neurons to their proper binding in competition experiments, suggesting the ex-
istence of a distinct PI-4,5P2 binding site [15]. The otherpositions during embryonic development. Targeted or
naturally occurring disruption of Dab1 in mice causes mammalian homolog of Drosophila Dab, Dab2, which
seems to participate in mediating endocytosis of differ-abnormal neuronal positioning in the cerebral cortex
and the hippocampus, as well as cerebellar dysplasia ent LDL receptor-related proteins, also selectively binds
PI-4,5P2 at a site that does not prevent peptide binding[3, 4].
The Dab1 null phenotype is identical to that of the [19], suggesting that a distinct PI binding site has been
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evolutionarily conserved in these two related proteins,
which exhibit 60% identity in their PTB domains.
To understand the basis for selective recognition of
peptides with an unphosphorylated tyrosine at the 0
position, we determined the structure of the Dab1 PTB
domain in complex with a 14-residue peptide from the
ApoER2 cytoplasmic tail. The structure of the complex,
determined at 1.5 A˚ resolution, indicates how this PTB
domain selectively binds peptides with the φxNPxY
consensus sequence and why unphosphorylated tyro-
sine is preferred. The structure of the PTB domain-pep-
tide complex also reveals the presence of a basic patch
on the surface of the PTB domain on the face opposite
the peptide binding groove; by soaking PTB-peptide
cocrystals in PI-4,5P2, we also determined the site of
PI-4,5P2 binding within this patch in a ternary complex.
Results and Discussion
Primary sequence alignment and secondary structure
prediction indicated that the region of homology be-
tween Dab1 and known PTB domains extends from resi-
due 23 to 174. The construct chosen for production
of the Dab1 PTB domain in bacteria spanned residues
20–175 (Dab1 PTB domain hereafter) to ensure inclusion
of the entire domain with minimal flexibility at either
terminus (Figure 1A).
Because this Dab1 PTB domain polypeptide differs
at both termini from other previously studied Dab1 con-
structs [9, 15], we first verified that our purified Dab1
PTB domain associates with peptides derived from the
cytoplasmic tails of ApoER2 and VLDLR in a pull-down
assay. When glutathione beads are loaded with GST
fusion proteins displaying either the ApoER2 or VLDLR
peptide, the Dab1 PTB domain is indeed recovered with
the beads, whereas it is not pulled down by GST alone
(Figure 1B).
The dissociation constants of different Dab1 PTB do-
main-peptide complexes were then measured directly
by isothermal titration calorimetry (ITC) and/or fluores-
cence polarization. The Kd of the complex between the
ApoER2 14-mer (Ac-TKSMNFDNPVYRKT-CONH2) and
the PTB domain, measured by ITC, is 1.5  0.3 M
(Figure 1C), an affinity comparable to that previously
measured by fluorescence for binding of a 17-residue
APP peptide to a different Dab1 PTB domain-GST fusion
construct [15] and within the range seen for complexes
of peptides with PTB domains from other proteins [20–
22]. Further analysis of the ITC data indicates that theFigure 1. Dab1 Domain Organization, Formation of PTB-ApoER2
binding of the ApoER2 peptide is enthalpy driven, asPeptide Complexes, and Measurement of Affinity
seen for the binding of peptides to the PTB domains of(A) Schematic diagram of Dab1. The five regulatory tyrosines down-
IRS1 and SNT-1 [21, 23] and in contrast to binding ofstream of the PTB domain are indicated, and sites of alternative
splicing are marked with an asterisk. peptides to the Shc PTB domain [23]. Competition bind-
(B) GST pull-down of the Dab1 PTB domain by the ApoER2 and ing experiments by fluorescence polarization show that
VLDLR cytoplasmic domains (ApoER2-C and VLDLR-C). Bound pro- a 10-mer ApoER2 peptide, from which the four N-ter-
tein was subjected to SDS-PAGE and visualized by staining with minal residues have been deleted, binds the PTB domain
Coomassie blue.
of Dab1 with an affinity indistinguishable from that of(C) Measurement of the dissociation constant of the complex be-
the 14-mer ApoER2 peptide (data not shown).tween the Dab1 PTB domain and a 14-residue peptide from the
ApoER2 tail by isothermal titration calorimetry (ITC). A stock solution
of the peptide (170 M) was added in 7.5 l increments into a 20
Crystallization and Overview of StructureM solution of the Dab1 PTB domain. To calculate the dissociation
To understand the basis for recognition of the 14-merconstant, we fitted data to a one-site binding model with the program
Origin 5.0. by the Dab1 PTB domain, we solved the crystal structure
Structures of Dab1 PTB Domain Complexes
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Figure 2. Electron Density, Overview of
Structure, and Sequence Alignment
(A) Representative electron density (con-
toured at 1  after refinement) from the res-
idues surrounding the NPVY motif of the
peptide in the Dab1 PTB domain-peptide
complex. Peptide residues, yellow; protein
residues, green.
(B) Ribbon representation of the Dab1 PTB
domain in stereo colored according to sec-
ondary structure, with bound peptide ren-
dered in ball and stick form.
(C) Structure-based alignment of the Dab1
PTB domain with other PTB domains and a
representative PH domain. Secondary struc-
ture elements are colored as in (B). Residues
in the Dab1 PTB domain that interact with the
ApoER2 peptide are colored cyan (hydrogen
bonds), green (hydrophobic interactions), or
yellow (both). Residues of the Dab1 PTB do-
main and the PLC PH domain that contact
PI-4,5P2 are enclosed in blue boxes, as are
the aligned residues of the Dab2 and ARH
sequences. Numbers above the alignment re-
fer to residue positions in Dab1. Residue po-
sitions for the other proteins are shown to the
right of the aligned sequences.
of this complex by multiwavelength anomalous disper- domain (M65 and M66) alone failed to provide enough
phasing power to solve the structure.sion (MAD) to 1.5 A˚ resolution (Figure 2A; Table 1). The
phase information was derived from selenomethionine- The Dab1 PTB domain exhibits a canonical PTB fold,
in which seven central  strands form two antiparallel,substituted Dab1 harboring an L87M mutation because
the two consecutive native methionines of the Dab1 PTB near-orthogonal  sheets, capped by a long C-terminal
Structure
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Table 1. Crystallographic Data Collection and Refinement
L87M (MAD)
Native Remote Peak Edge PI-4,5P2 Soaked
Data Collection
Wavelength (A˚) 0.909 0.95004 0.97815 0.97872 1.5418
Resolution (A˚) 1.5 1.9 2.0 2.0 1.9
(outer shell)a (1.5–1.54) (1.9–1.98) (2.0–2.07) (2.0–2.07) (1.9–1.96)
Total reflections 141,192 71,181 128,475 128,909 34,852
Unique reflections 24,532 11,465 10,278 10,309 12,179
Completeness (%)a 99.5 (98.9) 94.1 (68.9) 96.9 (81.1) 96.9 (80.9) 98.0 (97.5)
Rmerge (%)a,b 5.2 (23.5) 4.2 (13.6) 4.9 (9.0) 4.1 (9.4) 4.7 (17.0)
Figure of merit (before/ 0.779 / 0.852
after DM)c
Refinement
Resolution range (A˚) 40–1.5 40–1.9
Number of reflections 24,472 11,884
Rwork/Rfree (%)d 0.222/0.245 0.204/0.253
Number of atoms (main chain/side chain/all chains, residues)
mDab1 609/592/1201, 23–174 609/592/1201, 23–174
Peptide 41/48/89, 5–14 41/48/89, 5–14
Water 160 151
PO4 or PI-4,5P2 5 48




PO4 or PI-4,5P2 33.73 40.57
Rms bond length (A˚) 0.004 0.005
Rms bond angles () 1.12 1.08
a Values in parentheses are for reflections in the highest resolution bin.
b Rmerge  hi |Ih,i 	 (Ih)|/hiIh,I, where Ih,i is the intensity of the ith measurement of h and (Ih) is the corresponding average value for all i
measurements.




) is the phase probability distribution and 
 is the phase.
d Rwork and Rfree  ||Fo| 	 |Fc||/|Fo| for the working set and test set (10%) of reflections.

 helix (Figure 2B). Even though all PTB domains for and 3B). These global conformational features of the
which structures have been solved share a low level of bound peptide are also seen in most other structures
sequence identity, structure-based alignment reveals of peptides bound to PTB domains.
that this core topological framework is universally con- The Dab1 PTB domain contacts the side chains of
served (Figure 2C). Unique insertions building upon this the bound peptide at a number of sites (Figures 3A
framework are occasionally found; the Dab1 PTB do- and 3B). Phe 	5 of the peptide packs tightly into a
main, like the PTB domains of Shc, X11, and Numb [20, hydrophobic groove created by Ile151, Leu154, the ali-
24, 25], contains an insertion between strands 1 and phatic part of Arg155, and Phe158 of the C-terminal 

2 that forms an extra  strand as well as a long 
 helix helix, explaining the preference for Phe or Tyr at this
(Figures 2B and 2C). The PTB domain of Dab1 includes position [15]. The carboxylate of the adjacent Asp at 	4
a short N-terminal 
 helix also seen in the corresponding forms a saltbridge with the guanidino group of Arg56.
regions of the Shc and Numb PTB domains. The Asn of the NPVY sequence forms two H bonds
between the hydrogen atoms of its NH2 group and main
chain carbonyl oxygens of Val110 and Ile113 of the PTBPeptide Conformation
domain. The side chain carbonyl oxygen of this AsnThe Dab1 PTB domain binds the ApoER2 peptide in a
residue in the Dab1-peptide complex also participateshydrophobic groove formed by the 5 strand and the
in an intrapeptide H bond with the Val 	1 backboneC-terminal helix in a mode like that seen in the Shc-,
amide to initiate the  turn formed by the NPxY motif.IRS-1-, X11-, and Numb-peptide complexes [20, 22, 24,
In the structures of peptides bound to other PTB do-26]. In the Dab1-peptide complex, the four N-terminal
mains, the corresponding Asn residues form similar hy-residues of the peptide (positions 	7 to 	10; Figure 3A)
drogen bonds, and the presence of this Asn is vital forare disordered, explaining why a 10-mer lacking these
peptide recognition [20, 26]. The type I  turn of theresidues has comparable affinity for the Dab1 PTB do-
NPVY sequence positions the Tyr 0 residue in a cleftmain. Asn 	6 to Asp 	4 of the peptide adopt an ex-
formed by His111, Glu112, and Ser114, enabling forma-tended conformation, forming backbone hydrogen
tion of an H bond between the Tyr 0 side chain OH andbonds with residues in the 5 strand to add another
the backbone carbonyl of Gly131 (Figures 3A and 4A).strand to the C-terminal  sheet of the PTB domain; the
adjacent NPxY motif forms a type I  turn (Figures 3A The conformation of the polypeptide backbone from
Structures of Dab1 PTB Domain Complexes
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Figure 3. Dab1 PTB Domain-Peptide Con-
tacts
(A) ApoER2 peptide sequence with schematic
indicating contacts between the peptide and
the Dab1 PTB domain. Hydrogen bonds, dot-
ted cyan lines; hydrophobic contacts, green.
(B) Stereo representation of contacts. For the
peptide, side chains are yellow, and residue
labels are black. For the PTB domain, side
chains are cyan, and residue labels are pur-
ple. A transparent surface of the PTB domain
is shown in white, and the PTB domain back-
bone is illustrated with ribbons. Hydrogen
bonds, dashed blue lines.
Asn 	6 to Tyr 0 of the central NPxY sequence is nearly with 7 is different in other PTB domains of known struc-
ture (Figure 2C). In particular, the same loop in X11 isidentical to that of the corresponding region of the APP
peptide bound to the X11 PTB domain [20]. The APP much longer and disordered in the crystal, and the 6
strand in X11 does not extend as far toward the Tyr ofpeptide in its conformation from the X11 cocrystal struc-
ture readily superimposes onto the ApoER2 peptide the peptide. The mobility of these loops may enable X11
to bind both Tyr and pTyr sequences, while the limitedbound to Dab1 (Figure 4A, top panel). This superposition
shows that the PTB domain of Dab1 can accommodate flexibility of the short loops combined with the closer
approach of the 6 strand in Dab1 only accommodatesthe APP peptide with Tyr 0 in a similar position and
without steric clashes elsewhere, consistent with the Tyr (Figures 3B and 4A). Whereas the long 
2 helix of
Dab1 packs against the 1, 6, and 7 strands, holdingknown ability of an overlapping APP peptide to bind to
the PTB domain of Dab1 with low micromolar affinity [15]. the 6-7 loop in place and constraining the Tyr 0 bind-
ing pocket, IRS-1 lacks 1 and the long 
2 helix andA distinct feature of the Dab1 PTB domain is its strong
preference for unphosphorylated Tyr at the 0 position. instead features a much shorter helix that connects
strands 1 and 2, but does not approach the Tyr 0This discrimination highlights a key difference between
Dab1 and X11 because X11 does not readily distinguish binding pocket, allowing adequate space for the phos-
phate group (Figure 4B, top panel). Finally, the 6-7between Tyr and pTyr [20]. Selection against pTyr by
Dab1 is established by a cleft created by the short loops loop of IRS-1 also contains a bulge imposed by a GPG
sequence (residues 232–234) at its C-terminal end [26].connecting 4 with 5 and 6 with 7 (Figures 3B and
4A), which closely approach the tyrosine side chain and The two glycine residues of the GPG bulge make back-
bone H bonds to residues on either side of Arg227, andshould sterically exclude the bulkier pTyr. This cleft is
capped at one end by the loop connecting 1 with the the proline buttresses the aliphatic part of the Arg 227
side chain. These interactions situate Arg227 in posi-central helix. The tight turn connecting strands 6 and
7 of the mDab1 PTB domain packs against this cap. tion to form a salt bridge with the pTyr phosphate group
and, together with Arg 212, create the positively chargedThis arrangement results in an H bond between the
tyrosine hydroxyl and the backbone carbonyl of Gly131 pocket dictating the preference for pTyr in IRS-1 (Fig-
ure 4B).(Figures 3 and 4A, bottom panel) and also places the
His136 imidazole ring within van der Waals contact of Of note, a homology model of a complex between the
ICAP-1
 PTB domain and a 1 integrin peptide alsothe tyrosine hydroxyl. The presence of this H bond also
explains the observed strong preference for Tyr over predicts that this PTB domain should prefer to bind
peptides with unphosphorylated Tyr within the NPxYPhe at the 0 position [15].
In contrast, the corresponding loop connecting 6 motif. In that model, which is of high structural quality
Structure
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Figure 4. Comparison of the Dab1 PTB Domain-ApoER2 Complex with Other PTB Complexes
(A) Top panel, superposition of the APP peptide onto the Dab1 PTB domain-ApoER2 peptide complex. The molecular surface representation
of the Dab1 PTB domain is colored by electrostatic potential (	15 kt/e [red] to 15 kt/e [blue]). The ApoER2 (gray) and APP (green) peptides
are rendered in stick form, and the lysine side chain of the ApoER2 peptide has been removed for clarity. Bottom panel, close-up view of the
boxed region highlighting the residues interacting with the Tyr 0 residue of the ApoER2 peptide. The protein backbone is shown as a ribbon,
while selected peptide (yellow) and protein (cyan) side chains are in stick form. Hydrogen bonds, dashed blue lines.
(B) The IRS-1 PTB domain-pTyr peptide complex. Top panel, the molecular surface representation of the IRS-1 PTB domain [26] is colored
by electrostatic potential (as in [A]) to illustrate the basic pocket responsible for phosphotyrosine binding. The bound insulin receptor peptide
is rendered in stick form. Bottom panel, close-up view of the boxed region to highlight the residues interacting with the pTyr of the insulin
receptor peptide. Colored as in (A), except that the protein side chains are green.
and has a backbone rmsd of 1.05 A˚ to our X-ray structure chains derived from the residues in the loops connecting
adjacent secondary structural elements. To test whetherfor all alignable residues (460 atoms), the ICAP-1
 PTB
domain also has a short loop connecting 4 with 5, this basic patch encompasses the PI-4,5P2 binding site
and concurrently determine how PI-4,5P2 binds to theand the 6-7 loop is predicted to project an Ile side
chain toward the Tyr of the peptide, thereby discriminat- PTB domain, we soaked PTB-peptide cocrystals in
mother liquor containing PI-4,5P2.ing between Tyr and pTyr [27].
Crystals soaked with PI-4,5P2 show strong density for
the phosphates in the 4 and 5 positions, with additionalA Mechanism for Membrane Recruitment
The selective binding of PI-4,5P2 by both Dab1 and Dab2 contiguous density from the inositol ring and 1-phos-
phate groups. The observed density is best modeled bymay direct recruitment of these proteins to the mem-
brane [15, 19]. PI-4,5P2 binding may control mechanisms the binding of PI-4,5P2 in either of two orientations (see
Experimental Procedures), which are related to eachof transport of Dab family proteins within cells and/or
their localization within specific membrane compart- other by a 180 rotation around an axis bisecting the 4-
and 5-phosphate groups and perpendicular to the C4-ments, like lipid rafts. In addition, in ways not yet under-
stood, PI-4,5P2 binding may also participate in integrat- C5 bond of the inositol ring (Figure 5). The primary differ-
ence between these two orientations is defined by theing the binding of the ApoER2 cytoplasmic tail with other
events in signaling, for example, by facilitating kinase- position of the 1-phosphate group because PI-4,5P2 is
pseudosymmetric around the rotation axis. The pre-catalyzed tyrosine phosphorylation of Dab1 or by cou-
pling of the receptor-Dab1 complex to downstream sig- ferred conformation (by a 70:30 ratio, as estimated by
occupancy refinement; see Experimental Procedures)naling pathways [28, 29].
How does Dab1 bind PI-4,5P2? The structure of the situates the 1-phosphate close to Arg76, and we there-
fore discuss interactions of the PI-4,5P2 with the PTBPTB domain-peptide complex reveals a distinct region
of positive electrostatic surface potential on the surface domain using that orientation.
In this model, the phosphates of PI-4,5P2 interact withof the PTB domain opposite the peptide binding groove.
This patch results from a coalescence of basic side six of the residues that make up the conserved basic
Structures of Dab1 PTB Domain Complexes
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Figure 5. Electron Density of PI-4,5P2 Bound
to the Dab1 PTB Domain
Bound PI-4,5P2 was modeled in two orienta-
tions related by a 180 axis of rotation. PI-
4,5P2 in the preferred orientation, based on
occupancy refinement (see Experimental
Procedures), CPK colors; the orientation with
the lower occupancy, orange. Orange mesh,
Fo 	 Fc map after refinement of a model with
PI-4,5P2 in the less occupied orientation, con-
toured at 2.5 . Note the large regions of re-
sidual electron density overlapping the posi-
tions of the 1-phosphate and the 2-hydroxyl
in the preferred orientation. Green mesh, Fo 	
Fc map after refinement of a model with PI-
4,5P2 in the preferred orientation, contoured
at 2.5 . Note the residual region of electron density overlapping the position of the 1-phosphate in the other orientation. Blue mesh, 2Fo 	
Fc map, contoured at 1 , of a composite model including refined coordinates of both PI-4,5P2 orientations weighted by occupancy. Protein
side chains interacting with bound PI-4,5P2 are indicated.
region on the Dab1 PTB domain surface (Figures 2C phate of the preferred orientation to form a salt bridge
to one of the terminal oxygen atoms (Figure 5).and 5). Two 4-phosphate oxygens are coordinated by
the guanidino group of Arg124 from the N-terminal end The residues that comprise the phosphoinositide
binding site are conserved among a subset of PTB do-of 6 and the -amino group of Lys142 from the
C-terminal end of 7. His81 coordinates one of the main-containing proteins homologous to Dab1 (Figure
6). All of the residues that contact PI-4,5P2 are strictly5-phosphate oxygen atoms, and the -amino groups of
Lys45 and Lys82 are in position to coordinate terminal conserved in the sequence of Dab2, which also binds
PI-4,5P2 and otherwise harbors only 60% identity tooxygen atoms from both the 4- and 5-phosphates. The
side chain of Arg76 is also close enough to the 1-phos- Dab1 in its PTB domain [30]. A Dab1-based homology
Figure 6. The PI-4,5P2 Binding Site Is Shared by Dab1, Dab2, and PLC, but Not by X11 and Shc
(A) The Dab1 PTB domain, oriented with the peptide binding groove at the base and the N-terminal residues of the bound peptide projecting
toward the viewer. The PI-4,5P2 binding site is on the top face, opposite the peptide binding groove. Dab1-based homology models of the
Dab2 (B) and the ARH (C) PTB domains show that the location of the positively charged PI-4,5P2 binding site is conserved (arrows).
(D) The PH domain from PLC bound to PI-4,5P2 [33]. The basic residues that form the PI-4,5P2 binding site in PLC structurally align with
the amino acids that create the PI-4,5P2 binding site in Dab1. The X11 (E) and Shc (F) PTB domains lack the basic residues that make up the
PI-4,5P2 binding site. All molecular surface representations were generated by the program GRASP [46] and shaded by electrostatic potential
(	15 kt/e [red] to 15 kt/e [blue]).
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model of the Dab2 PTB domain also predicts the pres-
ence of a comparable basic region at the same location
(Figure 6B), further suggesting that the conservation of
the basic patch is important for the function of both
proteins. In addition, these basic residues are also con-
served in the ARH protein (Figure 2C), another PTB do-
main-containing protein that shares the ability to bind
both the cytoplasmic tails of LDL receptor family mem-
bers and PI-4,5P2 [31, 32]. A homology model of ARH
based on the Dab1 structure shows that these residues
would similarly form a basic PI binding surface (Figure
6C), suggesting that membrane recruitment may be a
general feature of interactions between LDL receptor
family members and their adaptor proteins. Finally, the
PI-4,5P2 binding site of a representative PH domain,
the one from phospholipase C, [33] consists of basic
residues in loops connecting secondary structural ele-
ments, which also align structurally with the residues
used by Dab1 (Figures 2C and 6D), suggesting a poten-
tial evolutionary relationship between Dab1 and the PI
binding PH domains.
The basic patch is a distinguishing feature of the
Dab1-like subset of PTB domains because the corre-
sponding residues are not conserved in other PTB do-
mains of known structure, like those of the X11 and Shc
proteins (Figures 6E and 6F). In such proteins, there may
either be no need for membrane recruitment (although
Figure 7. A Model for the Arrangement of the Dab1-ApoER2 Com-the Shc PTB domain may bind weakly to PI-4P and PI-
plex at the Membrane Surface
4,5P2 at a site that appears to compete with peptide Structure of the ternary complex of the Dab1 PTB domain (ribbon
binding using residues distinct from the ones identified trace, colored as in Figure 2A), ApoER2 peptide (blue sticks), and
here [24, 34, 35]) or this function may be fulfilled by PI(4,5)P2 (cyan- and CPK-colored sticks), arranged to illustrate that
another domain of the protein. For example, in IRS-1, membrane recruitment of the PTB domain by PI(4,5)P2 is fully com-
patible with binding to the ApoER2 cytoplasmic tail. The positionsan adjacent PH domain binds to PIs to bring IRS-1 to
of the remainder of the ApoER2 receptor cytoplasmic tail (blue dots)the membrane [36].
and the phospholipid membrane are highly schematized in theThe PTB domain of Dab1 combines the peptide bind-
model.
ing features of typical PTB domains with the PI binding
properties characteristic of most PH domains (Figure 7).
To understand the basis for selective recognition ofThis combination of membrane recruitment and peptide
peptides with an unphosphorylated tyrosine at the 0binding by a single domain suggests that these activities
position and to identify potential sites for PI binding, weare functionally coupled. Membrane recruitment of the
determined the structure of the Dab1 PTB domain inDab1 PTB domain by the basic region may help to orient
complex with a 14-residue peptide from the ApoER2the ligand binding groove with respect to the ApoER2
cytoplasmic tail. The structure of the Dab1 PTB domain-peptide, which lies only 10 residues from the trans-
peptide complex explains why the Dab1 PTB domainmembrane sequence. Selectivity of the PTB domain for
strongly prefers peptide ligands in which the Tyr of thePI-4,5P2 may serve to concentrate the Dab1 signaling
NPxY motif is not phosphorylated. Although it is notcomplex in membrane patches that are highly enriched
known whether the NPxY motif of either lipoprotein re-in this phospholipid, thus facilitating coupling to, and
ceptor tail undergoes phosphorylation, the preferenceactivation of, PI-3 Kinase, a component of a downstream
for unphosphorylated tyrosine shows that it would bebranch of the Reelin signaling pathway [28].
possible to regulate downstream signaling by modulat-
ing the tyrosine phosphorylation state of the receptor
tails.Biological Implications
In the ternary complex of the Dab1 PTB domain, pep-
tide, and PI-4,5P2, the PI-4,5P2 binds to the large basicControl of neuronal migration during development de-
pends on a signaling pathway that includes the secreted patch on the face of Dab1 opposite the peptide binding
groove. These studies provide the first structural charac-protein Reelin, the ApoER2 and VLDLR cell surface re-
ceptors, and the adaptor protein Dab1. Dab1 binds to terization of a hybrid PTB domain to which both peptide
and PI-4,5P2 have been simultaneously bound and pro-an NPxY-containing motif in the cytoplasmic tails of
ApoER2 and VLDLR via its N-terminal PTB domain. Both vide support for models in which Dab1 function is en-
abled or regulated by PI binding. Control of membraneDab-1 and the related protein Dab-2 also bind PI-4,5P2,
suggesting that the activity of Dab-1 may also depend localization by PI binding may regulate Dab1 activity by
facilitating downstream events that accompany peptideon or be regulated by recruitment to PI-enriched mem-
brane compartments. binding, such as tyrosine phosphorylation by mem-
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calculate a dissociation constant, we plotted data and peformedbrane-associated kinases. In addition, the ability of
curve fitting with the program Origin 5.0. For fluorescence polariza-Dab1 to bind to PIs may itself be diminished when the
tion measurements, a fluorescent derivative of the 14-residuetyrosine residues adjacent to the PTB domain are phos-
ApoER2 peptide was prepared by conjugation of 5-iodoacetami-
phorylated upon activation of a Reelin signal [7, 37, dofluorescein to acetyl-CGGTKSMNFDNPVYRKT-amide (the 14-
38]. Insights from our structures of Dab1 PTB-ApoER2 residue tail peptide extended with a CGG N-terminal linker) through
a thioether linkage. After HPLC purification, the peptide was dis-peptide complexes should open up several new lines
solved in 20 mM Na2HPO4 (pH 6.8), 150 mM NaCl, and 0.2 mM DTT,of investigation to clarify the role of PI binding by Dab1
and its concentration was determined by measuring the absorbancein living cells.
of fluorescein at 492 nm. Measurements of fluorescence anisotropy
were carried out on an SLM/AMINCO AB2 luminescence spectro-Experimental Procedures
photometer fitted with polarizers (Thermospectronic) at 25C in 20
mM Na2HPO4 buffer (pH 6.8) containing 150 mM NaCl and 0.2 mMSubcloning, Protein Expression, and Purification
DTT. Aliquots of the Dab1 PTB domain (up to a final concentrationof the Dab1 PTB Domain
of 5 M) were titrated into a solution of 50 nM fluorescent peptide,The sequence encoding the PTB domain of Dab1 (residues 20–175)
and the polarization value was measured. The binding curve waswas amplified by PCR from a full-length cDNA clone (kindly provided
fit to a single site model to determine the dissociation constant. Forby Brian Howell). The PCR product was introduced into the pDEST15
competition measurements of fluorescence polarization with thevector downstream of glutathione S-transferase (GST) without the
unconjugated 14-residue peptide and the shorter 10-residue tailuse of restriction sites by recombinational Gateway cloning (In-
peptide (acetyl-NFDNPVYRKT-amide), aliquots of unconjugatedvitrogen); a tobacco etch virus (TEV) protease cleavage site was
peptide were added to a solution of 50 nM fluorescent peptide inintroduced between GST and the Dab1 PTB domain during subclon-
the presence of 500 nM Dab1 PTB domain.ing. The L87M mutation, which enabled incorporation of seleno-
methionine into the protein for structure determination by MAD, was
Protein Crystallizationcarried out by PCR mutagenesis with a QuickChange site-directed
The purified PTB domain of mDab1 was concentrated to 15–25 mg/mutagenesis kit (Stratagene). Native and selenomethionine-labeled
ml in 50 mM Tris buffer (pH 6.8) containing 50 mM NaCl and 5 mMfusion proteins were expressed in E. coli BL21(DE3) and in E. coli
DTT. Complexes of the PTB domain with the ApoER2 14-residueB834(DE3) methionine-auxotrophic cells, respectively, by induction
peptide were then prepared by mixing the peptide in a 1:1–1:1.5with IPTG (0.4 mM). For purification of native and selenomethionine-
molar ratio with protein. Initial crystals grew from 2 l hanging dropslabeled proteins, cells were lysed either by sonication or with a
(1 l well solution mixed with 1 l concentrated protein solution)French press in 20 mM Na2HPO4 buffer (pH 6.8) containing 150 mM
after 5 weeks at room temperature in 0.1 M HEPES (pH 7.5), 20%NaCl, 20% sucrose, 1 mM EDTA, 5–10 mM DTT, 200 M PMSF, 1
PEG4000, and 10% isopropanol. Crystals were obtained in 2–3 daysg/ml aprotonin, and 0.5 g/ml leupeptin (buffer A). After each GST-
by mixing 2 l of protein/peptide solution with 2 l of 0.1 M HEPESDab1 fusion protein was captured on glutathione-Sepharose beads
(pH 7.5), 34%–36% PEG8000, and 5% ethanol over a well solution(Pharmacia), the PTB domain was released from bound GST by
of 0.1 M HEPES (pH 7.5) and 34%–36% PEG8000 and by macroseed-cleavage with His6-tagged TEV protease. After removal of TEV prote-
ing 24 hr after the drops were set. Selenemethionine-derivatizedase from solution with Ni-NTA agarose (Qiagen), the native and
crystals grew in 7–10 days under the same conditions. The crystalsselenomethionine-labeled proteins were then purified to apparent
belong to the space group P212121 and have cell dimensions of a homogeneity by anion exchange followed by gel filtration chroma-
36.25 A˚, b  45.72 A˚, and c  90.12 A˚.tography. For crystallography, purified proteins were concentrated
and dialyzed into 50 mM Tris buffer (pH 6.8) containing 50 mM NaCl
Data Collection and Structure Determinationand 5 mM DTT. For binding studies and biophysical measurements,
All diffraction data were collected at 100 K after slow transfer of thethe protein was dialyzed exhaustively against a solution of 10 mM
crystals into mother liquor to which 5% PEG400 had been addedNa2HPO4 buffer (pH 6.8) containing 150 mM NaCl and 5 mM DTT.
for cryoprotection. A native data set to 1.5 A˚ was collected at the
Cornell High Energy Synchrotron Source (Cornell University) withGST Pull-Down
the F1 beamline with an ADSC Quantum4 CCD detector. A secondThe cytoplasmic tails of ApoER2 (ApoER2-C) and VLDLR (VLDLR-C)
data set was also collected to 1.8 A˚ with a selenomethionine crystalwere expressed as GST fusion proteins with a modified version of
from the L87M protein with a rotating anode source (Rigaku RU-the pGEX-4T-1 vector (Pharmacia) that harbors a TEV protease site
200EBH) with a mar300 Image Plate Detector (mar research). Oscilla-before the polylinker. The GST-fusion proteins, as well as GST alone,
tion images were indexed and integrated with DENZO [39], and thewere expressed in E. Coli BL21(DE3) cells by induction with IPTG.
intensities were scaled and merged with the program SCALEPACKCell were lysed by sonication in buffer A. The lysates were gently
[39]. The same L87M crystal was used to collect diffraction dataagitated together with glutathione-Sepharose beads (Pharmacia) to
to 2.0 A˚ at three wavelengths for MAD phasing at the Nationalpermit binding of the GST fusion proteins. After three washes with
Synchrotron Light Source (Brookhaven National Laboratory) with10 mM Na2HPO4 (pH 7.5), 150 mM NaCl, 5 mM DTT, and 0.5% NP-
the X12C beamline with a B4 CCD detector. MAD data were pro-40 (buffer B), glutathione-Sepharose beads loaded either with GST-
cessed with the HKL2000 program suite [39]. The scaled intensityApoER2-C, GST-VLDLR-C, or GST alone (10 l) were gently rocked
data from the three MAD wavelengths were input into the programin the presence of the purified Dab1 PTB domain (10 M) in buffer
SOLVE [40] to locate heavy atom sites. Two selenium sites wereB (1.0 ml) for 2 hr at 4C. The beads were recovered by centrifugation,
located, and the phases generated by SOLVE were refined withwashed three times in buffer A (1 ml), and resuspended in 50 l of
RESOLVE [40] and the program DM in the CCP4 program suite [41].SDS-PAGE loading buffer. After boiling for 10 min, bound proteins
With the 1.5 A˚ native data set and the program ARP/wARP [42],were separated by SDS-PAGE with a 15% gel and were visualized
the phases were further improved, and an atomic model (90%by staining with 0.1% Coomassie brilliant blue.
complete) was built in an automatic fashion. The model was com-
pleted and manually refit with the program O [43], and simulatedBinding Measurements
annealing, energy minimization, and B factor refinement were per-The affinities of the purified Dab1 PTB domain for 10- and 14-residue
formed with CNS [44]. Further refinement included the addition ofApo-ER2 tail peptides were measured by isothermal titration calo-
water molecules as well as a phosphate ion to the model and thenrimetry (ITC) and/or by fluorescence polarization. For ITC measure-
further cycles of CNS refinement.ments, a 14-residue synthetic peptide from the ApoER2 cytoplasmic
tail (Research Genetics; acetyl-TKSMNFDNPVYRKT-amide) was pu-
rified by reversed-phase HPLC for titration into a solution of the PI-4,5P2 Soaking and Ternary Complex
Structure DeterminationDab1 PTB domain. A stock solution of the tail peptide (170 M) was
added in 7.5 l increments to a 20 M solution of Dab1 at 25C in Native crystals of the Dab1 PTB domain-ApoER2 peptide complex
were soaked for 14 days in 50 l of mother liquor containing 0.550 mM Tris (pH 6.8) containing 150 mM NaCl and 0.2 mM DTT. To
Structure
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mM PI-4,5P2 (Sigma). A 1.9 A˚ data set was collected on one of these matrix proteins deleted in the mouse mutant reeler. Nature 374,
719–723.crystals with a rotating anode source (Rigaku RU-200EBH) with a
mar300 Image Plate Detector (mar research). Data were processed 6. Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J.,
Stockinger, W., Nimpf, J., Hammer, R.E., Richardson, J.A., andwith DENZO and SCALEPACK as above. The amplitudes from this
data set and the phases from the Dab1 PTB domain-peptide com- Herz, J. (1999). Reeler/Disabled-like disruption of neuronal mi-
gration in knockout mice lacking the VLDL receptor and ApoEplex structure were used to generate an electron density map of
the ternary complex. The map showed strong density for the phos- receptor 2. Cell 97, 689–701.
7. Hiesberger, T., Trommsdorff, M., Howell, B.W., Goffinet, A.,phates in the 4 and 5 positions. The density for the inositol ring and
the 1-phosphate group indicated that the PI-4,5P2 adopts either of Mumby, M.C., Cooper, J.A., and Herz, J. (1999). Direct binding
of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosinetwo possible orientations in the soaked crystals (see text). Occu-
pancy refinement of these two alternate conformations assigned an phosphorylation of disabled-1 and modulates tau phosphoryla-
tion. Neuron 24, 481–489.occupancy of 0.7 to the preferred orientation, in which the
1-phosphate approaches within H bonding distance of the Arg76 8. D’Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D.S., Shel-
don, M., and Curran, T. (1999). Reelin is a ligand for lipoproteinguanidino group, and an occupancy of 0.3 to the other orientation.
receptors. Neuron 24, 471–479.Simulated annealing, energy minimization, and B factor refinement
9. Trommsdorff, M., Borg, J.P., Margolis, B., and Herz, J. (1998).were performed with CNS for both of the models. The two sets of
Interaction of cytosolic adaptor proteins with neuronal apolipo-refined PI-4,5P2 coordinates were then combined into a final model
protein E receptors and the amyloid precursor protein. J. Biol.with weighted occupancy, from which the 2Fo 	 Fc map of Figure
Chem. 273, 33556–33560.5 was generated.
10. Gotthardt, M., Trommsdorff, M., Nevitt, M.F., Shelton, J., Rich-
ardson, J.A., Stockinger, W., Nimpf, J., and Herz, J. (2000).Homology Modeling and Molecular Graphics
Interactions of the low density lipoprotein receptor gene familyThe models of the PTB domain from murine Disabled-2 (Dab2) and
with cytosolic adaptor and scaffold proteins suggest diverseof human ARH1 were prepared with the program Modeller [45].
biological functions in cellular communication and signal trans-Figures were prepared with the programs GRASP [46], MOLSCRIPT
duction. J. Biol. Chem. 275, 25616–25624.[47], and PyMol (DeLano Scientific; http://www.pymol.org).
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